Mirko Zimic Selected Research

Leishmaniasis

1/2018	IFN-γ Response Is Associated to Time Exposure Among Asymptomatic Immune Responders That Visited American Tegumentary Leishmaniasis Endemic Areas in Peru.
1/2016	Association of the Endobiont Double-Stranded RNA Virus LRV1 With Treatment Failure for Human Leishmaniasis Caused by Leishmania braziliensis in Peru and Bolivia.
1/2012	Prediction score for antimony treatment failure in patients with ulcerative leishmaniasis lesions.
8/2011	New salicylamide and sulfonamide derivatives of quinoxaline 1,4-di-N-oxide with antileishmanial and antimalarial activities.
6/2007	Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mirko Zimic Research Topics

Disease

25	Tuberculosis (Tuberculoses) 01/2022 - 12/2008
10	Multiple Organ Failure (MODS) 01/2022 - 06/2009
8	Infections 01/2022 - 01/2013
5	Human Influenza (Influenza) 04/2020 - 01/2013
5	Cysticercosis 03/2019 - 06/2009
5	Leishmaniasis 01/2018 - 06/2007
5	Neurocysticercosis 12/2015 - 12/2011
5	Cysts 12/2015 - 01/2011
4	COVID-19 01/2022 - 05/2021
3	Cough 01/2020 - 01/2016
3	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020 - 03/2010
3	Pulmonary Tuberculosis 01/2017 - 12/2008
2	Coinfection 01/2020 - 12/2016
2	Cutaneous Leishmaniasis 01/2012 - 06/2007
1	Latent Infection 06/2022
1	Body Weight (Weight, Body) 01/2022
1	Pneumonia (Pneumonitis) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Fascioliasis 01/2016
1	Inflammation (Inflammations) 12/2015
1	Malaria 08/2011
1	Neoplasms (Cancer) 04/2010
1	Communicable Diseases (Infectious Diseases) 04/2010
1	Silicosis 07/2008
1	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 12/2006
1	Critical Illness (Critically Ill) 10/2005
1	Diarrhea 01/2003

Drug/Important Bio-Agent (IBA)

20	Pharmaceutical PreparationsIBA 01/2022 - 06/2009
10	Pyrazinamide FDA LinkGeneric 01/2021 - 03/2010
7	AntigensIBA 03/2019 - 06/2009
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2009
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2003
4	AntibodiesIBA 01/2022 - 01/2011
4	Neuraminidase (Sialidase)IBA 11/2015 - 01/2013
3	pyrazinoic acidIBA 01/2021 - 01/2019
3	Peptides (Polypeptides)IBA 04/2020 - 01/2011
3	Cathepsin LIBA 03/2019 - 06/2009
3	pyrazinamide deamidaseIBA 12/2016 - 03/2010
3	Antiparasitic Agents (Antiparasitics)IBA 12/2015 - 08/2014
2	VaccinesIBA 01/2022 - 01/2015
2	Neutralizing AntibodiesIBA 12/2021 - 05/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2018
2	MetalsIBA 01/2020 - 08/2014
2	Immunoglobulin G (IgG)IBA 03/2019 - 01/2011
2	Praziquantel (Biltricide)FDA Link 12/2015 - 08/2014
2	EpitopesIBA 05/2013 - 01/2011
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 06/2022
1	PowdersIBA 01/2022
1	Culture MediaIBA 01/2022
1	AcidsIBA 01/2022
1	IgYIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 03/2019
1	ammonium ferrous sulfateIBA 01/2019
1	Phosphopyruvate Hydratase (Enolase)IBA 08/2018
1	CytokinesIBA 01/2018
1	Benzophenoneidum (Auramine O)IBA 01/2016
1	GranulinsIBA 01/2016
1	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2016
1	NucleotidesIBA 12/2015
1	LigandsIBA 11/2015
1	lipoarabinomannan (LAM)IBA 01/2015
1	Albendazole (Albenza)FDA Link 08/2014
1	Anticonvulsants (Antiepileptic Drugs)IBA 08/2014
1	Cysteine Proteases (Cysteine Protease)IBA 07/2013
1	Biological ProductsIBA 07/2013
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2013
1	Oseltamivir (Tamiflu)FDA Link 01/2013
1	Zanamivir (Relenza)FDA Link 01/2013
1	IonsIBA 07/2012
1	AntimonyIBA 01/2012
1	ThrombospondinsIBA 12/2011
1	TrypsinIBA 12/2011
1	quinoxaline-2-carbonitrileIBA 08/2011
1	Antimalarials (Antimalarial Agents)IBA 08/2011
1	BR 76 (BR 1376)IBA 08/2011
1	Rifampin (Rifampicin)FDA LinkGeneric 05/2010
1	HydrazonesIBA 04/2010
1	EnzymesIBA 06/2009
1	ImmunosorbentsIBA 06/2009
1	chelexIBA 12/2008
1	Silicon Dioxide (Silica)FDA LinkGeneric 07/2008
1	SYBR Green IIBA 12/2006
1	Hormones (Hormone)IBA 10/2005

Therapy/Procedure

6	Therapeutics 01/2022 - 01/2012
3	Drug Therapy (Chemotherapy) 01/2016 - 06/2007